Grupo de Inversiones Suramericana SA operates as a holding company that engages in the management of portfolio investments and financial services. The firm's activities are divided into three business segments: Fund Management, Insurance and Services. The Fund Management division is responsible for the administration of mandatory and voluntary pension funds, as well as provision of life annuities and other savings products. The Insurance segment offers life and non-life insurance policies. The Services area includes outsourcing services in the field of telecommunications and information processing, mandatory healthcare services and medical plans, as well as other complementary services. The firm's investment portfolio comprises Sura Asset Management, Suramericana, Bancolombia, Grupo Argos, Grupo Nutresa, Habitat, Sodhexo and Enka, among others. The firm operates through numerous subsidiaries in Latin America, including Colombia, Mexico, Chile, Peru, El Salvador and Panama, among others.
Grupo de Inversiones Suramericana S.A.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Aclaris Therapeutics Inc 주요 수익원은 Novel Small and Large Molecule Product이며, 최신 수익 발표에서 수익은 7,826,000입니다. 지역별로는 United States이 Aclaris Therapeutics Inc의 주요 시장이며, 수익은 7,826,000입니다.
Grupo de Inversiones Suramericana S.A.은 수익성이 있나요?
no, 최신 재무제표에 따르면 Aclaris Therapeutics Inc의 순손실은 $0입니다.
Grupo de Inversiones Suramericana S.A.에 부채가 있나요?
no, Aclaris Therapeutics Inc의 부채는 0입니다.
Grupo de Inversiones Suramericana S.A.의 발행 주식은 몇 주인가요?